Skip to main content
Top
Published in: BMC Nephrology 1/2015

Open Access 01-12-2015 | Case report

Case report: anti-glomerular basement membrane antibody disease with normal renal function

Authors: China Nagano, Yoshimitu Goto, Katuaki Kasahara, Yoshiyuki Kuroyanagi

Published in: BMC Nephrology | Issue 1/2015

Login to get access

Abstract

Background

Anti-glomerular basement membrane (GBM) antibody disease is a rare autoimmune disorder characterized by rapidly progressive glomerulonephritis caused by autoantibodies against the α3-chain of type IV collagen in the GBM.

Case presentation

An 8-year-old girl with hematuria and proteinuria due to anti-GBM nephritis was diagnosed with hematuria and proteinuria during a school urine screening program. Her blood pressure and serum creatinine levels were normal. Her hematuria and proteinuria persisted for several months. Since a spot urine protein to creatinine ratio was around 7 g/g Cre, a percutaneous renal biopsy was performed. Immnofluorescent staining demonstrated a linear pattern for immunoglobulin G along the entire GBM. Chest computed tomography was normal. Anti-GBM antibody assays were reported as slightly raised; thus, the diagnosis was anti-GBM disease with normal renal function. Treatment included plasma exchange, intravenous high-dose methylprednisolone, and cyclophosphamide as a mainstay medication. The treatment was rapidly effective with an immediate decrease in anti-GBM titers and proteinuria.

Conclusions

Cases of anti-GBM disease with normal renal function in children are rare. Treatment in children has not been established; therefore, clinicians need to carefully select an effective treatment because the prognosis is poor.
Literature
1.
go back to reference Hellmark T, Segelmark M. Diagnosis and classification of Goodpasture's disease (anti-GBM). J Autoimmun. 2014;48–49:108–12.CrossRefPubMed Hellmark T, Segelmark M. Diagnosis and classification of Goodpasture's disease (anti-GBM). J Autoimmun. 2014;48–49:108–12.CrossRefPubMed
2.
go back to reference Bayat A, Kamperis K, Herlin T. Characteristics and outcome of Goodpasture's disease in children. Clin Rheumatol. 2012;31:1745–51.CrossRefPubMed Bayat A, Kamperis K, Herlin T. Characteristics and outcome of Goodpasture's disease in children. Clin Rheumatol. 2012;31:1745–51.CrossRefPubMed
3.
go back to reference Silvariño R, Noboa O, Cervera R. Anti-glomerular basement membrane antibodies. Isr Med Assoc J. 2014;16:727–32.PubMed Silvariño R, Noboa O, Cervera R. Anti-glomerular basement membrane antibodies. Isr Med Assoc J. 2014;16:727–32.PubMed
4.
5.
go back to reference Cui Z, Zhao MH, Singh AK, Wang HY. Antiglomerular basement membrane disease with normal renal function. Kidney Int. 2007;72:1403–8.CrossRefPubMed Cui Z, Zhao MH, Singh AK, Wang HY. Antiglomerular basement membrane disease with normal renal function. Kidney Int. 2007;72:1403–8.CrossRefPubMed
6.
go back to reference Ang C, Savige J, Dawborn J, Miach P, Heale W, Clarke B, et al. Anti-glomerular basement membrane (GBM)-antibody-mediated disease with normal renal function. Nephrol Dial Transplant. 1998;13:935–9.CrossRefPubMed Ang C, Savige J, Dawborn J, Miach P, Heale W, Clarke B, et al. Anti-glomerular basement membrane (GBM)-antibody-mediated disease with normal renal function. Nephrol Dial Transplant. 1998;13:935–9.CrossRefPubMed
7.
go back to reference Cui Z, Wang HY, Zhao MH. Natural autoantibodies against glomerular basement membrane exist in normal human sera. Kidney Int. 2006;69:894–9.CrossRefPubMed Cui Z, Wang HY, Zhao MH. Natural autoantibodies against glomerular basement membrane exist in normal human sera. Kidney Int. 2006;69:894–9.CrossRefPubMed
8.
go back to reference Williamson SR, Phillips CL, Andreoli SP, Nailescu C. A 25-year experience with pediatric anti-glomerular basement membrane disease. Pediatr Nephrol. 2011;26:85–91.CrossRefPubMed Williamson SR, Phillips CL, Andreoli SP, Nailescu C. A 25-year experience with pediatric anti-glomerular basement membrane disease. Pediatr Nephrol. 2011;26:85–91.CrossRefPubMed
9.
go back to reference Kluth DC, Rees AJ. Anti-glomerular basement membrane disease. J Am Soc Nephrol. 1999;10:2446–53.PubMed Kluth DC, Rees AJ. Anti-glomerular basement membrane disease. J Am Soc Nephrol. 1999;10:2446–53.PubMed
10.
go back to reference Kumazaki S, Umeda Y, Sato K, Mishima H, Ishihara T, Uzawa T. [Double filtration plasmapheresis in case of Goodpasture's syndrome]. Nihon Kyobu Shikkan Gakkai Zasshi. 1990;28:628–633. [Article in Japanese] Kumazaki S, Umeda Y, Sato K, Mishima H, Ishihara T, Uzawa T. [Double filtration plasmapheresis in case of Goodpasture's syndrome]. Nihon Kyobu Shikkan Gakkai Zasshi. 1990;28:628–633. [Article in Japanese]
11.
go back to reference Hajime N, Michiko A, Atsunori K, Tatsuo K, Yuko N, Naoki O, et al. A case report of efficiency of double filtration plasmapheresis in treatment of Goodpasture's syndrome. Ther Apher Dial. 2009;13:373–7.CrossRefPubMed Hajime N, Michiko A, Atsunori K, Tatsuo K, Yuko N, Naoki O, et al. A case report of efficiency of double filtration plasmapheresis in treatment of Goodpasture's syndrome. Ther Apher Dial. 2009;13:373–7.CrossRefPubMed
Metadata
Title
Case report: anti-glomerular basement membrane antibody disease with normal renal function
Authors
China Nagano
Yoshimitu Goto
Katuaki Kasahara
Yoshiyuki Kuroyanagi
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2015
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-015-0179-1

Other articles of this Issue 1/2015

BMC Nephrology 1/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.